From EAE to an MS clinical trial: DR2/MOG-35-55 recombinant T cell receptor ligand (RTL) treats relapse of experimental encephalomyelitis in DR2 transgenic mice

被引：0
|
作者：
Offner, Halina
Burrows, Gregory
Vandenbark, Arthur
Link, Jason
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Portland VA Med Ctr, Portland, OR USA
来源：
CLINICAL IMMUNOLOGY | 2007年 / 123卷
关键词：
D O I：
10.1016/j.clim.2007.03.191
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 10 条
  • [1] From EAE to MS clinical trial: DR2/MOG-35-55 recombinant T cell receptor ligand (RTL) treats relapse of EAE in DR2 transgenic mice
    Vandenbark, A. A.
    Burrows, G. G.
    Offner, H.
    Link, J.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2007, 102 : 290 - 290
  • [2] Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice
    Link, Jason M.
    Rich, Cathleen M.
    Korat, Maya
    Burrows, Gregory G.
    Offner, Halina
    Vandenbark, Arthur A.
    [J]. CLINICAL IMMUNOLOGY, 2007, 123 (01) : 95 - 104
  • [3] From EAE to an MS clinical trial: DR 2/MOG-35-55 recombinant T cell receptor ligand treats relapses of experimental encephalomyelitis in DR 2 transgenic mice
    Vandenbark, A.
    Burrows, G.
    Offner, H.
    Link, J.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 163 - 163
  • [4] Design, engineering, and production of human recombinant T cell receptor ligands derived from human leukocyte antigen DR2
    Chang, JW
    Mechling, DE
    Bächinger, HP
    Burrows, GG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (26) : 24170 - 24176
  • [5] Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice
    Vandenbark, AA
    Rich, C
    Mooney, J
    Zamora, A
    Wang, CH
    Huan, JY
    Fugger, L
    Offner, H
    Jones, R
    Burrows, GG
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 171 (01): : 127 - 133
  • [6] Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice
    Masse-Ranson, Guillemette
    Dusseaux, Mathilde
    Fiquet, Oriane
    Darche, Sylvie
    Boussand, Maud
    Li, Yan
    Lopez-Lastra, Silvia
    Legrand, Nicolas
    Corcuff, Erwan
    Toubert, Antoine
    Centlivre, Mireille
    Bruel, Timothee
    Spits, Hergen
    Schwartz, Olivier
    Levy, Yves
    Strick-Marchand, Helene
    Di Santo, James P.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (06) : 954 - 965
  • [7] Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice
    Rich, C
    Link, JM
    Zamora, A
    Jacobsen, H
    Meza-Romero, R
    Offner, H
    Jones, R
    Burrows, GG
    Fugger, L
    Vandenbark, AA
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (05) : 1251 - 1261
  • [8] Recombinant TCR ligand (RTL) treats MBP-85-99 actively induced EAE in mice expressing transgenes for both MBP-85-99-specific TCR and HLA-DR2
    Link, JM
    Rich, C
    Burrows, GG
    Vandenbark, AA
    [J]. FASEB JOURNAL, 2004, 18 (05): : A1171 - A1171
  • [9] Neuroprotective Effects of Recombinant T-cell Receptor Ligand in Autoimmune Optic Neuritis in HLA-DR2 Mice
    Adamus, Grazyna
    Brown, Lori
    Andrew, Shayne
    Meza-Romero, Roberto
    Burrows, Gregory G.
    Vandenbark, Arthur A.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (01) : 406 - 412
  • [10] Differential induction of experimental autoimmune encephalomyelitis by myelin basic protein molecular mimics in mice humanized for HLA-DR2 and an MBP85-99-specific T cell receptor
    Greene, Maria T.
    Ercolini, Anne M.
    DeGutes, Mathew
    Miller, Stephen D.
    [J]. JOURNAL OF AUTOIMMUNITY, 2008, 31 (04) : 399 - 407
1